- Home
- TNGX vs LSEA Comparison
TNGX vs LSEA Comparison
Compare TNGX & LSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- LSEA
- Stock Information
- Founded
- TNGX 2014
- LSEA 2013
- Country
- TNGX United States
- LSEA United States
- Employees
- TNGX N/A
- LSEA N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- LSEA Homebuilding
- Sector
- TNGX Health Care
- LSEA Consumer Discretionary
- Exchange
- TNGX Nasdaq
- LSEA Nasdaq
- Market Cap
- TNGX 317.4M
- LSEA 222.1M
- IPO Year
- TNGX N/A
- LSEA N/A
- Fundamental
- Price
- TNGX $1.10
- LSEA $6.10
- Analyst Decision
- TNGX Strong Buy
- LSEA Buy
- Analyst Count
- TNGX 7
- LSEA 4
- Target Price
- TNGX $12.33
- LSEA $13.50
- AVG Volume (30 Days)
- TNGX 542.7K
- LSEA 200.4K
- Earning Date
- TNGX 05-12-2025
- LSEA 05-12-2025
- Dividend Yield
- TNGX N/A
- LSEA N/A
- EPS Growth
- TNGX N/A
- LSEA N/A
- EPS
- TNGX N/A
- LSEA 0.47
- Revenue
- TNGX $42,069,000.00
- LSEA $1,550,337,000.00
- Revenue This Year
- TNGX N/A
- LSEA N/A
- Revenue Next Year
- TNGX N/A
- LSEA $3.52
- P/E Ratio
- TNGX N/A
- LSEA $12.98
- Revenue Growth
- TNGX 15.17
- LSEA 28.13
- 52 Week Low
- TNGX $1.11
- LSEA $5.41
- 52 Week High
- TNGX $12.02
- LSEA $14.04
- Technical
- Relative Strength Index (RSI)
- TNGX 33.44
- LSEA 48.21
- Support Level
- TNGX $1.38
- LSEA $5.79
- Resistance Level
- TNGX $1.56
- LSEA $6.25
- Average True Range (ATR)
- TNGX 0.16
- LSEA 0.31
- MACD
- TNGX -0.01
- LSEA 0.04
- Stochastic Oscillator
- TNGX 9.90
- LSEA 43.02
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.